Premium
Salvage therapy with decitabine in combination with granulocyte colony‐stimulating factor, low‐dose cytarabine, and aclarubicin in patients with refractory or relapsed early T‐cell precursor acute lymphoblastic leukemia
Author(s) -
Meng Tongyan,
Yao Yao,
Xu Yang,
Xue Shengli,
Han Yue,
Tang Xiaowen,
Qiu Huiying,
Sun Aining,
Wu Depei,
Zhang Yanming,
Wang Ying
Publication year - 2020
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2783
Subject(s) - aclarubicin , medicine , cytarabine , decitabine , refractory (planetary science) , granulocyte colony stimulating factor , salvage therapy , oncology , lymphoblastic leukemia , cancer research , leukemia , chemotherapy , chemistry , biology , biochemistry , gene expression , astrobiology , dna methylation , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom